HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/6/G1289    most recent 00543.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (24) Citing Articles via Google Scholar Google Scholar Articles by Burdyga, G. Articles by Dockray, G. J. Search for Related Content PubMed PubMed Citation Articles by Burdyga, G. Articles by Dockray, G. J.

HORMONES AND SIGNALING

Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance

¹Physiological Laboratory, School of Biomedical Sciences, University of Liverpool, Liverpool; and ²Department of Gastroenterology, Hope Hospital, University of Manchester, Manchester, United Kingdom

Submitted 29 November 2005 ; accepted in final form 17 January 2006

Intact vagal afferent neurons are required for the satiety effects of the intestinal hormone cholecystokinin (CCK) and the orexigenic effects of the gastric regulatory peptide ghrelin. In this study, we examined the localization of ghrelin receptors in nodose ganglia and their function in regulating the expression of other orexigenic receptors, notably cannabinoid (CB)-1 and melanin-concentrating hormone (MCH)-1 receptors. With the use of RT-PCR, transcripts corresponding to both functional [growth hormone secretagogue receptor (GHS-R)1a] and truncated forms (GHS-R1b) of the ghrelin receptor were detected in rat nodose ganglia. There was no difference in expression between rats fed ad libitum or fasted for up to 48 h. Immunohistochemical studies using antibodies directed at GHS-R1a revealed expression in over 75% of neurons also expressing CCK-1 receptors in the mid- and caudal regions of the ganglion. There was also expression in human nodose ganglia. In fasted rats in which CB-1 and MCH-1 receptor expression was increased, administration of ghrelin prevented the downregulation by refeeding. We conclude that the actions of CCK and ghrelin are mediated by a common population of vagal afferent neurons. Ghrelin may act to limit the action of CCK in depressing expression of CB-1 and MCH-1 receptors and other receptors.

vagus nerve; satiety; appetite; melanin-concentrating hormone; cholecystokinin; cannabinoid

This article has been cited by other articles:

				G. Burdyga, G. de Lartigue, H. E. Raybould, R. Morris, R. Dimaline, A. Varro, D. G. Thompson, and G. J. Dockray Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the Stomach J. Neurosci., November 5, 2008; 28(45): 11583 - 11592. [Abstract] [Full Text] [PDF]

				A A Izzo and M Camilleri Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects Gut, August 1, 2008; 57(8): 1140 - 1155. [Abstract] [Full Text] [PDF]

				G. de Lartigue, R. Dimaline, A. Varro, and G. J. Dockray Cocaine- and Amphetamine-Regulated Transcript: Stimulation of Expression in Rat Vagal Afferent Neurons by Cholecystokinin and Suppression by Ghrelin J. Neurosci., March 14, 2007; 27(11): 2876 - 2882. [Abstract] [Full Text] [PDF]